NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
3.730
-0.490 (-11.61%)
At close: Sep 5, 2025, 4:00 PM
3.690
-0.040 (-1.07%)
After-hours: Sep 5, 2025, 8:00 PM EDT

NovaBay Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for NovaBay Pharmaceuticals stock has a target of 0.85, which predicts a -77.21% decrease from the current stock price of 3.73.

Price Target: $0.85 (-77.21%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$0.85$0.85$0.85$0.85
Change-77.21%-77.21%-77.21%-77.21%
* Price targets were last updated on Nov 11, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for NovaBay Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$8$0.85
Strong BuyMaintains$8$0.85-77.21%Nov 11, 2024
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$5,206$4,900
Strong BuyMaintains$5,206$4,900+131,267.29%May 20, 2022
Roth Capital
Roth Capital
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 26, 2018
Roth Capital
Roth Capital
Strong Buy
Initiates
$193
Strong BuyInitiates$193+5,060.86%Jun 5, 2017
Ascendiant Capital
Ascendiant Capital
Strong Buy
Initiates
$68,906
Strong BuyInitiates$68,906+1,847,252.55%Mar 6, 2013
More Analyst Ratings

Financial Forecast

Revenue This Year
12.12M
from 9.78M
Increased by 23.91%
Revenue Next Year
16.00M
from 12.12M
Increased by 32.05%
EPS This Year
-0.87
from -2.53
EPS Next Year
-0.38
from -0.87
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
9.93M10.20M14.40M10.46M9.78M12.12M16.00M
Revenue Growth
50.54%2.72%41.16%-27.42%-6.45%23.91%32.05%
EPS
-385.53-184.09-353.59-139.14-2.53-0.87-0.38
EPS Growth
-------
Forward PE
-------
No. Analysts
-----22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
High12.6M16.6M
Avg12.1M16.0M
Low11.8M15.5M

Revenue Growth

Revenue Growth20252026
High
28.8%
37.3%
Avg
23.9%
32.0%
Low
20.2%
28.1%

EPS Forecast

EPS20252026
High-0.90-0.40
Avg-0.87-0.38
Low-0.84-0.37

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.